Light therapy has a favourable safety profile relative to most interventions people try for pain, sleep or recovery. That is genuinely reassuring and also frequently overstated. "Generally safe for adults in studied applications" is a different sentence from "safe for everyone, at any dose, with any device" — and the difference is where the useful information lives.
What the Consensus Actually Says
A 2025 evidence-based consensus on the clinical application of photobiomodulation, published in the Journal of the American Academy of Dermatology, concluded that PBM is generally safe for adult patients and identified clinical applications supported by evidence. Two qualifiers travel with that conclusion: adults, and studied applications. Consumer devices marketed for unstudied uses at undisclosed parameters are not what was assessed.
The broader picture is consistent. The 2025 umbrella review of photobiomodulation spanning 204 randomized controlled trials did not describe a pattern of serious harm; its main criticisms concerned certainty of benefit rather than risk. A low-risk intervention with modest, condition-specific benefits is a fair characterization of the field today.
Who Should Ask a Physician First
There is a short, practical list. Anyone with a photosensitivity condition. Anyone taking a photosensitizing medication — several antibiotics, retinoids, some diuretics and certain psychiatric medications belong in this category, and the only reliable check is your prescriber or pharmacist. Anyone with an eye condition. Anyone with an active malignancy, particularly where a device would be used over the affected area. Anyone pregnant. Anyone with a seizure disorder, especially with flickering or pulsed light. Anyone considering use over a recent surgical site, an implanted device, or an undiagnosed skin lesion.
None of those are absolute prohibitions in every case. They are situations where an individual assessment matters more than a product manual.
The Dose Trap
The most common misuse is not a safety incident — it is over-treatment that quietly cancels the effect. Reviews of photobiomodulation mechanisms describe a biphasic dose response: below a threshold nothing measurable happens, and above an optimal window the effect attenuates. Doubling session length to accelerate results is therefore not a conservative choice. It is a different, untested one.
The Bigger Risk Is Substitution
In practice, the most serious harm associated with low-risk wellness devices is delay. Persistent pain, worsening sleep, low mood, cognitive change and skin lesions all have differential diagnoses that deserve evaluation. A device that feels productive can absorb the months in which a diagnosis should have been made. That is the risk worth naming plainly, and it applies to every modality including our own.
Proprietary Devices and Disclosure
Where parameters are proprietary — as with The Light System™, which reports bioelectrical and conductivity measurements and states that it makes no medical claims about the technology — a safety assessment cannot be transferred from published PBM trials. Undisclosed parameters mean unknown comparability. Ask the manufacturer for wavelengths, irradiance, recommended session limits, eye-protection guidance and stated contraindications, and treat the absence of answers as information.
A Reasonable Approach
Start conservatively, follow the manufacturer's session limits, protect the eyes, keep exposure consistent rather than escalating, review any medication for photosensitivity, and get anything persistent properly diagnosed. Used that way, light exposure is a low-risk wellness input inside a broader plan.
Continue with the full Light System™ research guide, the science of light therapy, or our medical disclaimer.
Educational information only. Not medical advice, not a diagnosis, and not an offer of The Light System™ as a service at Sanctuary Tulum. Always consult a qualified physician before beginning any new therapy.